| 1. A function of the liver | |
| a) | Makes fibrinogen | b) | Makes urea | c) | Makes cholesterol | d) | All of these |
| 2. Not a granulocyte | |
| a) | Thrombocyte | b) | Lymphocyte | c) | Monocyte | d) | All of these (none are granulocytes) |
| 3. Site of erythropoiesis (embryo to adult) | |
| a) | Yellow bone marrow | b) | Kidney | c) | Spleen | d) | A & B |
| 4. Type of anemia due to lack of vitamin B-12 in the diet | |
| a) | Nutritional | b) | Aplastic | c) | Pernicious | d) | None of these |
| 5. Urobilinogen | |
| a) | May be recycled back to the liver | b) | May lead to the formation of urobolin | c) | May lead to the formation of bilirubin | d) | Two of these |
| 6. The following are beta agonists (stimulate beta receptors) | |
| a) | Alupent | b) | Atrovent | c) | Mucomyst | d) | A & B |
| 7. Prevents coughing | |
| a) | Tessalon | b) | Diphenhydramine | c) | Potassium iodine | d) | Theophylline |
| 8. People with cirrhosis likely | |
| a) | Would have an ascites | b) | Would have esophageal varices | c) | Would be malnourished | d) | B & C |
| 9. Duct which leads directly to the gall bladder | |
| a) | Hepatic | b) | Bile | c) | Cystic | d) | Common Bile |
| 10. Bile salts | |
| a) | Aid in emulsification | b) | May form micelles | c) | Are absorbed in the duodenum and recycled | d) | A & B |
| 11. Term which describes making carbohydrates from amino acids | |
| a) | Transamination | b) | Glycogenolysis | c) | Glycogenesis | d) | None of these |
| 12. LDL's | |
| a) | Are made in the liver | b) | Increase in response to aerobic exercise | c) | Transport cholesterol to the liver | d) | All of these |
| 13. Needed to synthesize prothrombin | |
| a) | Vitamin K | b) | Calcium | c) | Prothrombin activation | d) | All of these |
| 14. Most common hepatitis worldwide | |
| a) | HBV | b) | HCV | c) | HDV | d) | HEV |
| 15. The Rathke's's pouch-derived portion of the pituitary secretes the following hormone (s) | |
| a) | Somatostatin | b) | ADH | c) | Melatonin | d) | None of these |
| 16. Mammotrophs | |
| a) | Produce oxytocin | b) | Produce estrogen | c) | Produce GnRH | d) | Are found in the adenohypophysis |
| 17. Causes secretion of milk | |
| a) | Oxytocin | b) | Progesterone | c) | Prolactin | d) | Estrogen |
| 18. Testosterone can be directly converted into | |
| a) | Androstenedione | b) | Estrone | c) | Progesterone | d) | None of these |
| 19. Part of the seminiferous tubule | |
| a) | Sertoli cells | b) | Leydig cells | c) | Epididymis | d) | All of these |
| 20. Sertoli cells produce | |
| a) | Sperm | b) | Estrogen | c) | Plasminogen activating factor | d) | Two of these |
| 21. XY males that lack estrogen receptors | |
| a) | Would likely not have testis | b) | Would likely have a developed Mullerian system | c) | Would likely have a clitoris | d) | Would likely be taller than normal counterparts |
| 22. Gland-like structure that secretes an alkaline fluid | |
| a) | Seminal vesicle | b) | Prostate | c) | Bulbourethral glands | d) | Epididymis |
| 23. A fetus without 5- alpha reductase | |
| a) | Could have testis | b) | Could have a seminal vesicles | c) | Could have a scrotum | d) | Two of these |
| 24. An individual with testicular feminizing syndrome | |
| a) | Lacks Mullerian inhibiting factor | b) | Is genetically XY | c) | Generally does not have a penis | d) | Two of these |
| 25. Part of the oviduct where fertilization normally takes place | |
| a) | Isthmus | b) | Fundus | c) | Infundibulum | d) | Ampulla |
| 26. Part of the pudendum | |
| a) | Vestibule | b) | Vagina | c) | Labia | d) | Two of these |
| 27. During the days generally associated with the proliferative phase | |
| a) | The cervical mucus is watery | b) | There is deposition of fat the breasts | c) | There is a corpus luteum | d) | A & B |
| 28. Thecal cells | |
| a) | May participate in producing androgens | b) | May participate in producing produce inhibin | c) | May participate in producing plasminogen activating factor | d) | All of these |
| 29. Causes embryonic testes to secrete testosterone | |
| a) | FSH | b) | LH | c) | HCG | d) | HCS |
| 30. Causes decidual cells to secrete nutrients | |
| a) | Estriol | b) | Relaxin | c) | HGG | d) | Progesterone |
| 31. Possible source of oxytocin | |
| a) | Anterior Pituitary | b) | Corpus luteum | c) | Thecal cells | d) | Uterus |
| 32. Effect of Epogen on the number of megakaryocyte | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 33. Effect of reduced amounts of iron on subsequent apoferitin synthesis | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 34. Hematocrit of someone with primary polycythemia as compared to someone with secondary polycythemia | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 35. Likelihood of finding bile in the hepatic artery as compared to finding it in the central vein | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 36. Plasma concentration of glucose in the hepatic artery as compared to the hepatic portal vein after having eaten a candy bar | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 37. Effect Questran on cholesterol synthesis | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 38. Effect of thromboxane A-2 on the conversion of prothrombin to thrombin | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 39. Number of steps in intrinsic pathway as compared to the extrinsic pathway | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 40. Effect of prostacyclins on platelet aggregation | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 41. Effect of streptase on the conversion of fibrinogen to fibrin | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 42. Effect of infant suckling on the release of oxytocin into the hypophyseal portal vein | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 43. Effect of CRH on ACTH secretion (direct effect) | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 44. Effect of growth hormone on lipolysis | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 45. Effect growth hormone on plasma glucose levels | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 46. Effect of growth hormone on bone growth at the level of the periosteum in a 30 year old male | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 47. Effect of the onset of puberty and plasma IGF-1 levels | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 48. Ability of a person with a vericoele to produce testosterone as compared to a normal person | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 49. Effect of DHT on fetal development of the scrotum as compared to DHT's effect on development of the scrotum at puberty | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 50. Effect of LH on ability of androgen binding protein to sequester androgens | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 51. FSH levels in a 80 year old male as compared to an 18 year old male | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 52. Number of corpora lutea per cycle as compared to the number of corpora albicans per cycle | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 53. Effect of FSH treatment on the number of new oocytes in a 10 year old female | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 54. Effect of estrogens on osteoblastic activity | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 55. Effect of high estrogen levels on GnRH secretion | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 56. Effect of RU-486 on GnRH levels | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 57. Effect of relaxin on material sensitivity to insulin | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 58. Effect of Danocrine on GnRH levels | |
| a) | Increase or greater than | b) | Decrease of less than | c) | No effect or equal to |
| 59. Effect of Motrin on estrogen levels | |
| a) | Increase or greater than | b) | No effect or equal to | c) | No effect or equal to |